Search
for

    Glossary Skindex-29

    validated questionnaire measuring skin disease impact on quality of life

    Skindex-29 is a validated questionnaire used to measure the impact of skin diseases on a patient's quality of life. It consists of 29 items that assess three main domains: symptoms, emotions, and functioning, providing a comprehensive overview of how skin conditions affect daily living and well-being.

    Related Terms

    Research 10 of 230

    1. The Polish version of Skindex-29: psychometric properties of an instrument to measure quality of life in dermatology Postepy Dermatologii I Alergologii · 2014 · 9 citations
    2. Responsiveness of the DLQI and the Colombian validated version of the Skindex-29 in scarring and non-scarring alopecia Skin Appendage Disorders · 2024
    3. Using Skindex-29 Scale to Assess The Impact of Androgenetic/Patterned Hair Loss on Quality of Life of Patients in Pakistan Pakistan Armed Forces Medical Journal · 2022
    4. Comparison of quality of life using hair-specific Skindex-29 between androgenetic alopecia and alopecia areata Journal of The American Academy of Dermatology · 2016
    5. Fase final de la validación transcultural al español de la escala Hair Specific Skindex-29: sensibilidad al cambio y correlación con la escala SF-12 Actas Dermo-Sifiliográficas · 2019 · 4 citations
    6. Final Phase in the Validation of the Cross-Cultural Adaptation of the Hair-Specific Skindex-29 Questionnaire Into Spanish: Sensitivity to Change and Correlation With the 12-Item Short-Form Health Survey Actas Dermo-Sifiliográficas · 2019 · 1 citations
    7. Quality of Life with Alopecia Areata versus Androgenetic Alopecia Assessed Using Hair Specific Skindex-29 Annals of Dermatology · 2018 · 13 citations
    8. Validación de una adaptación transcultural al idioma español de la escala Hair Specific Skindex-29 Actas Dermo-Sifiliográficas · 2018 · 9 citations
    9. Validation of a Cross-cultural Adaptation of the Hair Specific Skindex-29 Scale to Spanish Actas Dermo-Sifiliográficas · 2018
    10. Low quality of life and high HSS‐29 scores reflect the risk of loss to follow‐up: a study in patients with androgenetic alopecia Journal of The European Academy of Dermatology and Venereology · 2021
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →